0.775

2.27% 0.0172

After Hours: .75 -0.025 -3.23%

22nd Century Group, Inc. (XXII)

Overview News Price History Option Chain Discussions Forecast Stock Split

22nd Century Group, Inc. stock is traded at $0.775, with a volume of 180.73K. It is up +2.27% in the last 24 hours and down -56.70% over the past month. 22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

Previous Close:

$0.7578

Open:

$0.76

24h Volume:

180.73K

Relative Volume:

0.20

Market Cap:

$2.01M

Revenue:

$29.78M

Net Income/Loss:

$-39.94M

P/E Ratio:

-0.0125

EPS:

-61.9139

Net Cash Flow:

$-16.12M

1W Performance:

-18.67%

1M Performance:

-56.70%

6M Performance:

-94.34%

1Y Performance:

-99.65%

1-Day Range:

$0.74

$0.7799

1-Week Range:

$0.70

$0.94

52-Week Range:

$0.70

$265.95

22nd Century Group, Inc. Stock (XXII) Company Profile

Name

22nd Century Group, Inc.

Sector

Healthcare (1151)

Industry

Biotechnology (660)

Phone

716-270-1523

Address

8560 Main Street, Williamsville, NY

Employee

Twitter

@_xxiicentury

Next Earnings Date

2024-12-12

Latest SEC Filings

XXII's Discussions on Twitter

Compare XXII with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XXII 22nd Century Group, Inc.	0.775	2.01M	29.78M	-39.94M	-16.12M	-61.91
VRTX Vertex Pharmaceuticals Inc	489.10	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	563.16	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	596.20	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	234.56	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	230.98	26.16B	3.81B	-644.79M	-669.77M	-6.24

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-21-22	Initiated	Alliance Global Partners	Buy
Jun-15-22	Initiated	Craig Hallum	Buy
Mar-08-22	Initiated	ROTH Capital	Buy
Jul-23-21	Initiated	Cowen	Outperform
Oct-16-17	Reiterated	Chardan Capital Markets	Buy
Aug-11-16	Reiterated	Chardan Capital Markets	Buy

View All

22nd Century Group, Inc. Stock (XXII) Latest News

Apr 19, 2025

Buffalo Next - Buffalo News

Apr 19, 2025

Apr 17, 2025

22nd Century Settles Shareholder Derivative Actions - TipRanks

Apr 17, 2025

22nd Century Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions | XXII Stock News - GuruFocus

Apr 17, 2025

22nd Century Group, Inc. Announces Proposed Settlement of Stockholder Derivative Litigation - Nasdaq

Apr 17, 2025

22nd Century Reaches $768K Settlement in Stockholder Derivative Actions | XXII Stock News - Stock Titan

Apr 17, 2025

Apr 11, 2025

22nd Century Group Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN

Apr 11, 2025

Apr 10, 2025

22nd Century Group (XXII) Secures New Filtered Cigar Agreements - GuruFocus

Apr 10, 2025

Emerging Growth Research Releases Quarterly Update Report on 22nd Century Group (XXII) - The Globe and Mail

Apr 10, 2025

22nd Century Group (XXII) Unveils 2025 Growth Strategy and VLN® Brand Expansion - GuruFocus

Apr 10, 2025

22nd Century Group (XXII) Eyes Profit Growth with VLN Cigarettes in 2025 - GuruFocus

Apr 10, 2025

22nd Century Revenue Growth from Continued Expansion of CMO Volu - GuruFocus

Apr 10, 2025

Apr 09, 2025

22nd Century Group ramps up filtered cigar production By Investing.com - Investing.com Canada

Apr 09, 2025

22nd Century Revenue Growth from Continued Expansion of CMO Volume with New Filtered Cigar Agreements - The Manila Times

Apr 09, 2025

22nd Century Group ramps up filtered cigar production - Investing.com

Apr 09, 2025

22Nd Century Revenue Growth From Continued Expansion Of Cmo Volume - marketscreener.com

Apr 09, 2025

Apr 08, 2025

22nd Century Group plans expansion of low-nicotine cigarettes - Investing.com Australia

Apr 08, 2025

22nd Century Group plans expansion of low-nicotine cigarettes By Investing.com - Investing.com South Africa

Apr 08, 2025

22Nd Century CEO & Chairman Larry Firestone Provides Corporate Update - MarketScreener

Apr 08, 2025

22nd Century CEO & Chairman Larry Firestone Provides Corporate Update Letter to Stockholders - The Manila Times

Apr 08, 2025

22nd Century Slashes $18M Debt, Plans Massive VLN Cigarette Rollout to 272,000 Stores - Stock Titan

Apr 08, 2025

Green rush turns brown for some cannabis companies - Green Market Report

Apr 08, 2025

Apr 02, 2025

XXII stock plunges to 52-week low of $1.3 amid steep annual decline - Investing.com

Apr 02, 2025

Mar 25, 2025

XXII stock plunges to 52-week low, hits $1.65 amid market challenges - Investing.com

Mar 25, 2025

Mar 22, 2025

22nd Century Group, Inc. (NASDAQ:XXII) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 22, 2025

Mar 21, 2025

22nd Century reports $15.5 million loss for 2024; no net revenue from very-low-nicotine line - Winston-Salem Journal

Mar 21, 2025